Conference Papers
Zhong M; van der Walt A; Hodgkinson S; Kalincik T; Izquierdo G; Eichau S; Grand'Maison F; Lechner-Scott J; Buzzard K; Skibina O; Butler E; Prevost J; McCombe P; Van Pesch V; Oh J; Butzkueven H; Jokubaitis V, 2022, 'Time to relapse after switching to cladribine is predicted by relapse during the washout period', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 11 - 11, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022
Hardy T; Aouad P; Blum S; Broadley S; Carroll W; Crimmins D; Griffiths D; Hodgkinson S; Lechner-Scott J; Lee A; Malhotra R; Parratt J; Plummer C; Walt AVD; Walker R, 2022, '2258 Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in Australia', in Abstracts, BMJ Publishing Group Ltd, pp. A25.1 - A25, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.64
Vitkova M; Diouf I; Malpas C; Barnett M; Hodgkinson S; Butler E; Slee M; Taylor B; Butzkueven H; Lechner-Scott J; McCombe P; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, '2327 Latitude, UVR and multiple sclerosis severity', in Abstracts, BMJ Publishing Group Ltd, pp. A11.3 - A12, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.29
Maltby VE; Lea RA; Monif M; Fabis-Pedrini MJ; Buzzard K; Kalincik T; Kermode AG; Taylor B; Hodgkinson S; McCombe P; Osborne M; Butzkueven H; Barnett M; Lechner-Scott J, 2022, 'Cladribine: a multicentre, LOng-term efficacy and Biomarker Australian Study (CLOBAS)', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 26 - 26
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; van der Walt A; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, 'Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 5 - 6
Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; van der Walt A; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2022, 'Disease reactivation after cessation of diseasemodifying therapy in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 6 - 7
Zhong M; van der Walt A; Hodgkinson S; Kalincik T; Izquierdo G; Eichau S; Grand'Maison F; Lechner-Scott J; Buzzard K; Skibina O; Butler E; Prevost J; McCombe P; Van Pesch V; Oh J; Butzkueven H; Jokubaitis V, 2022, 'Time to relapse after switching to cladribine is predicted by relapse during the washout period', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 11 - 11
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; van der Walt A; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2022, 'Variability of the response to immunotherapy among sub-groups of patients with multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 7 - 7
Yeh WZ; Widyastuti PA; Walt AVD; Stankovich J; Havrdova EK; Horakova D; Vodehnalova K; Ozakbas S; Eichau S; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sá MJ; McCombe P; Grammond P; Ampapa R; Grand’Maison F; Bergamaschi R; Spitaleri DLA; Pesch VV; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Gresle M; Uher T; Maimone D; Turkoglu R; Hupperts RMM; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Jokubaitis VG; Registry M, 2021, '004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis', in Oral abstracts, BMJ Publishing Group Ltd, pp. A2.1 - A2, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.4
Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; Walt AVD; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2021, '006 Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in Oral abstracts, BMJ Publishing Group Ltd, pp. A3.1 - A3, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.6
Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; Walt AVD; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2021, '008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis', in Oral abstracts, BMJ Publishing Group Ltd, pp. A4.1 - A4, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.8
Butzkueven H; Spelman T; Kalincik T; Buzzard K; Walt AVD; Lechner-Scott J; Hodgkinson S; Butler E; Macdonell R; Slee M; Group MS; Marcel B, 2021, '010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort', in Oral abstracts, BMJ Publishing Group Ltd, pp. A4.3 - A5, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.10
Yeh W; Widyastuti P; Van der Walt A; Stankovich J; Gresle M; Havrdova E; Horakova D; Vodehnalova K; Ozakbas S; Eichau S; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sa MJ; Mccombe P; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Uher T; Maimone D; Turkoglu R; Hupperts R; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Jokubaitis V, 2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of relapse during pregnancy', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, pp. 30 - 31, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Hodgkinson S; Kalincik T; Buzzard K; Skibina O; Eichau Madueno S; Izquierdo G; Van der Walt A; Grand-Maison F; Butler E; Prevost J; Mccombe P; Oh J; Macdonell R; Lechner-Scott J; Van Pesch V; Duquette P; Prat A; Girard M; Kermode A; Fabris J, 2020, 'Real-world experience with cladribine tablets in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, pp. 549 - 549, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101671&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
De Stefano N; Achiron A; Barkhof F; Chan A; Derfuss T; Hodgkinson S; Leocani L; Montalbant X; Pratt A; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Roy S, 2020, 'A 2-year Study to Evaluate the Onset of Action of Cladribine Tablets in Subjects with Highly Active Relapsing Multiple Sclerosis: Results from MAGNIFY- MS Baseline Analysis', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, ELECTR NETWORK, pp. 685 - 686, presented at 6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 May 2020 - 26 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000534616801566&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Malpas CB; Roos I; Sharmin S; Butzkueven H; Kappos L; Patti F; Alroughani R; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Hodgkinson S; Grammond P; Lechner-Scott J; Kalincik T, 2019, 'Disease reactivation following fingolimod cessation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 330 - 331, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303101223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Patti F; Eichau S; Grand'Maison F; Kalincik T; Hodgkinson S; Skibina O; Butler E, 2019, 'Real-world experience with Cladribine in the MSBase Registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 326 - 327, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303101217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Patti F; Ozakbas S; Eichau S; Alroughani R; Terzi M; Boz C; Grand'Maison F; Grammond P; Kalincik T; Van Pesch V; Lechner-Scott J; Barnett M; Kuhle J; Hodgkinson S; Skibina O; Soysal A; Butler E; Slee M; Prevost J; Laureys G; Macdonell R; van Beek J; Craveiro L; Wormser D; Muros-Le Rouzic E, 2019, 'Real-world experience with Ocrelizumab in the MSBase Registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 539 - 540, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303102197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Hodgkinson S; Sharma M, 2019, 'Temporal profile of lymphocytes following treatment with cladribine tablets in patients switching from lymphocyte depleting or sequestering diseased modifying drugs (DMDs)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PA, Philadelphia, presented at 71st Annual Meeting of the American-Academy-of-Neurology (AAN), PA, Philadelphia, 04 May 2019 - 10 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000475965903372&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Haartsen J; Spelman T; Baker J; Agland S; Lechner-Scott J; Burke T; Vucic S; Rath L; Skibina O; Toubia M; Slee M; Taylor B; Mac Gregor S; Oconnell AM; Barnett M; Baker S; Sharma M; Hodgkinson S; Walters S; Kermode A; Hayes W; Butler E; Sheuy N; Shaw C; Portley R; Hardy T; Tan IL; Butzkueven H, 2017, 'MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 403 - 404, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Kister I; Spelman T; Patti F; Duquette P; Trojano M; Izquierdo G; Lugaresi A; Grammond P; Sola P; Ferraro D; Grand'Maison F; Alroughani R; Terzi M; Boz C; Hupperts R; Lechner-Scott J; Kapos L; Pucci E; Hodgkinson S; Solaro C; Butzkueven H, 2017, 'Predictors of relapses and disability progression after stopping disease-modifying therapies for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 356 - 357, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Jokubaitis VG; Havrdova E; Horakova D; Izquierdo G; Kalincik T; van der Walt A; Nguyen A-L; Terzi M; Alroughani R; Duquette P; Girard M; Prat A; Boz C; Sola P; Lugaresi A; Lechner-Scott J; Barnett M; Grand'Maison F; Grammond P; Ramo C; Turkoglu R; McCombe P; Hupperts R; Bolanos RF; Pucci E; Trojano M; Granella F; Spitaleri D; Van Pesch V; Soysal A; Oreja-Guevara C; Verheul F; Vucic S; Hodgkinson S; Slee M; Ampapa R; Prevost J; Menoyo JLS; Skibina O; Iuliano G; Solaro C; Olascoaga J; Shaw C; Madsen K; Naidoo K; Hyde R; Butzkueven H, 2017, 'Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 130 - 132, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Lechner-Scott J; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Solaro C; Grand'Maison F; Hupperts R; Prevost J; Sola P; Ferraro D; Terzi M; Butler E; Slee M; Kermode A; Fabis-Pedrini M; McCombe P; Barnett M; Shaw C; Hodgkinson S; Butzkueven H, 2017, 'Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 596 - 597, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730203308&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Kalincik T; Spelman T; Jokubaitis V; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Lugaresi A; Grammond P; Alroughani R; Lechner-Scott J; Prevost J; Terzi M; Grand'Maison F; Boz C; Trojano M; Van Wijmeersch B; Pucci E; Granella F; Turkoglu R; Sola P; Ferraro D; McCombe P; Solaro C; Van Pesch V; Ozakbas S; Slee M; Spitaleri D; Sanchez-Menoyo JL; Ampapa R; Hodgkinson S; Karabudak R; Vucic S; Butzkueven H, 2017, 'Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 325 - 327, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730202066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Spelman T; Schulz M; Arora B; Chung E; Juneja P; Walker R; Verhaeghe S; Butzkueven H; Hodgkinson S; Lechner-Scott J; McCombe P; Slee M; Butler E; Barnett M; Skibina O; Vucic S; Macdonell R; Shuey N; Taylor B; Broadley S, 2017, 'Persistence to fingolimod compared with other disease modifying therapies in the Australian real-world setting using the MS base registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 631 - 631, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730204050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jokubaitis V; Ai-Lan N; Kalincik T; van der Walt A; Lechner-Scott J; Barnett M; McCombe P; Vucic S; Hodgkinson S; Slee M; Skibina O; Shaw C; Butzkueven H, 2017, 'Pregnancy incidence, therapy exposure and post-partum relapse risk: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, pp. NP4 - NP4, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Firtko A; Thomas P; Hodgkinson S, 2017, 'Effect of Post-Acute Nurse Led Stroke Clinic (PASC) on readmissions rates for TIA/Stroke', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, pp. 10 - 11, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408220500026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jokubaitis VG; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Haartsen J; Liew D; Butzkueven H, 2013, 'Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 55 - 56, presented at 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, DENMARK, Copenhagen, 02 October 2013 - 05 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000328751400086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Cordato DJ; Thomas PR; Darshan G; Sanjeev T; Worthington JM; McDougall AJ; Hodgkinson SJ; Ibrahim HY; Griffith NC; Cappelen-Smith C; Beran RG, 2010, 'Decreasing Presentations of Seizures to Emergency Departments in a Large Australian Population', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, pp. A258 - A258, presented at 62nd Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 10 April 2010 - 17 April 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275274001259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
LINDSEY JW; HODGKINSON S; MEHTA R; ENZMANN D; SANDERS M; STEINMAN L, 1993, 'PHASE-I STUDY OF REPEATED TREATMENT WITH CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LIPPINCOTT-RAVEN PUBL, pp. A280 - A281, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KY35600489&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
LINDSEY JW; HODGKINSON S; MEHTA R; SIEGEL RC; MITCHELL DJ; LIM M; PIERCY C; TRAM T; DORFMAN L; ENZMANN D; STEINMAN L, 1992, 'PHASE-1 CLINICAL-TRIAL OF CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LITTLE BROWN CO, CA, SAN DIEGO, pp. 413 - 419, presented at 44th Annual Meeting of the American-Academy-of-Neurology, CA, SAN DIEGO, http://dx.doi.org/10.1212/WNL.44.3_Part_1.413
Conference Proceedings (Editor of)
Wang CC; Li J; Tran GT; Hodgkinson SJ; Hall BM; Mccaughan GW; Allen R; Bishop GA, (eds.), 2005, 'Immunology and Cell Biology', Blackwell Publishing Asia, Carlton, Victoria, Australia, presented at 23rd Annual Scientific Meeting of the Transplantation Society of Australia and NZ, Canberra, 11 May 2005 - 13 May 2005
Conference Presentations
Husin H; Wallace J; Malpas C; Sharmin S; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Prat A; Girard M; Duquette P; Trojano M; Grammond P; Lugaresi A; Onofrj M; Ozakbas S; Butzkueven H; Sola P; Ferraro D; Alroughani R; Grand'Maison F; Terzi M; Lechner-Scott J; Boz C; Hupperts R; Shaygannejad V; Bergamaschi R; Pucci E; Van Pesch V; Hodgkinson S; McCombe P; Granella F; Slee M; Van Wijmeersch B; Karabudak R; Prevost J; Petersen T; Spitaleri D; Barnett M; Solaro C; Iuliano G; Verheul F; Ramo-Tello C; Turkoglu R; Fernandez Bolanos R; Butler E; Macdonell R; Soysal A; Betancur MM; Kalincik T, 2018, 'Determinants of MS re-activation after discontinuing therapies', presented at 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), GERMANY, Berlin, 10 October 2018 - 12 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446861400464&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Ledingham D; El-Wahsh S; Cappelen-Smith C; Hodgkinson S; McDougall A; Maley M; Cordato D, 2018, 'PARADOXICAL REACTION IN TUBERCULOUS MENINGITIS: A TERTIARY REFERRAL HOSPITAL RETROSPECTIVE EXPERIENCE OF CONCOMITANT IMMUNOSUPPRESSION THERAPY', presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Darwin, 29 May 2018 - 01 June 2018, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.17
Conference Abstracts
Al-atiyah R; Verma N; Kawalia P; Tran G; Hodgkinson S; Hall B, 2024, 'Activation of human CD4+CD25+CD127lo Treg with alloantigen and rIL-2 induces IFNGR', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065872.18320.b6
Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-atiyah R; Suranyi M; Spicer T; Wong J; Tran G; Hodgkinson S; Hall B; Verma N, 2024, 'B cell phenotypes in peripheral blood of patients with renal allograft.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065376.80110.31
Verma N; Kawalia P; Al-atiyah R; Tran G; Rakesh P; Carter N; Hodgkinson S; Bruce H, 2024, 'Human CD4+CD25+CD127lo Treg can be activated in vitro with alloantigen and rIL-4 to induce receptor for interleukin 5 (IL-5Ra).', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065108.83650.af
Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-atiyah R; Suranyi M; Spicer T; Wong J; Tran G; Hodgkinson S; Hall B; Verma N, 2024, 'T regulatory cell phenotypes in renal transplant patients with long surviving graft, increased Th2-like Treg and reduced Th1-and Th17-like Treg.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065100.92615.5f
Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-Atiyah R; Suranyi M; Spicer T; Wong J; Hodgkinson SJ; Hall BM; Verma ND, 2024, 'Examination of subsets of CD4+lymphocyte subpopulations in long-surviving renal transplant patients', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, SWEDEN, Stockholm, Vol. 39, presented at 61st Congress of European-Renal-Association (ERA), SWEDEN, Stockholm, 23 May 2024 - 26 May 2024, http://dx.doi.org/10.1093/ndt/gfae069.1666
Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-Atiyah R; Suranyi M; Spicer T; Wong J; Hodgkinson SJ; Hall BM; Verma ND, 2024, 'Monitoring of peripheral blood B cell subsets in long-surviving renal transplant patients', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, SWEDEN, Stockholm, Vol. 39, presented at 61st Congress of European-Renal-Association (ERA), SWEDEN, Stockholm, 23 May 2024 - 26 May 2024, http://dx.doi.org/10.1093/ndt/gfae069.952
Harding-Forrester S; Roos I; Nguyen AL; Malpas CB; Diouf I; Moradi N; Sharmin S; Izquierdo G; Eichau S; Patti F; Horakova D; Kubala Havrdova E; Prat A; Girard M; Duquette P; Grand'Maison F; Onofrj M; Lugaresi A; Grammond P; Ozakbas, S; Amato MP; Gerlach O; Sola P; Ferraro D; Buzzard K; Skibina O; Lechner-Scott J; Alroughani R; Boz C; Van Pesch V; Cartechini E; Terzi M; Maimone D; Ramo-Tello C; Yamout B; Khoury SJ; La Spitaleri D; Sa MJ; Blanco Y; Granella F; Slee M; Butler E; Sidhom Y; Gouider R; Bergamaschi R; Karabudak R; Ampapa R; Sánchez-Menoyo JL; Prevost J; Castillo-Trivino T; McCombe PA; Macdonell R; Laureys G; Van Hijfte L; Oh J; Altintas A; De Gans K; Turkoglu R; Van Der Walt A; Butzkueven H; Vucic S; Barnett M; Cristiano E; Hodgkinson S; Iuliano G; Kappos L; Kuhle J; Shaygannejad V; Soysal A; Weinstock-Guttman B; Van Wijmeersch B; Kalincik T, 2023, 'Disability accrual in primary and secondary progressive multiple sclerosis', in Journal of Neurology Neurosurgery and Psychiatry, Vol. 94, pp. 707 - 717, http://dx.doi.org/10.1136/jnnp-2022-330726
Butzkueven H; Spelman T; Ozakbas S; Kalincik T; Boz C; Buzzard K; Skibina O; Alroughani R; Karabudak R; Van der Walt A; Lechner-Scott J; Hodgkinson S; Laureys G; Van Hijfte L; Terzi M; Butler E; Macdonell R; Patti F; Van Pesch V; Slee M; Barnett M; Grammond P; Prevost J; Grand-Maison F; Taylor B; Kermode A; Mccombe P; Duquette P; Prat A; Girard M; Eichau Madueno S; Izquierdo G; Soysal A; Sanchez-Menoyo JL; Sotoca J; Muros-Le Rouzic E; Dirks P, 2020, 'Real-world experience with ocrelizumab in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 550 - 551, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020
Pender MP; Hodgkinson SJ; Broadley S; Lindsey J; Ioannides ZA; Bagert B; Khanna R; Smith C; Gamelin L; Ye W; Willmer J; Bar-Or A, 2020, 'Phase i study of ata188, an off-the-shelf, allogeneic epstein-barr virus-targeted t-cell immunotherapy for progressive forms of multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 228 - 228, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100451&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jokubaitis V; Yeh W; Widyastuti P; Stankovich J; Gresle M; Havrdova EK; Horakova D; Vodehnalova K; Ozakbas S; Madueno SE; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sa MJ; Mccombe P; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Uher T; Maimone D; Turkoglu R; Hupperts R; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Van der Walt A, 2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of postpartum relapse and disability progression', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 652 - 653, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547102220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
O'Neill D; Sharma M; Gonzales B; Vandenheuval M; Tse B; Hodgkinson S, 2020, 'Switching from ocrelizumab to cladribine: real world data', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 67 - 68, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Verma N; O'Neill D; Al-Atiyah R; Sharma M; Tran G; Hall B; Hodgkinson S, 2020, 'The effect of cladribine upon naive and activated cd4(+) t regulatory cells in ms patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 314 - 314, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101180&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Maltby V; Lydon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T; Lechner-Scott J, 2020, 'Cladribine: a multicentre LOng-term efficacy Biomarker Australian Study (CLOBAS)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Sharmin S; Bovis F; Malpas C; Horakova D; Havrdova E; Ayuso GI; Eichau S; Trojano M; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Ferraro D; Terzi M; Hupperts RMM; Alroughani R; Boz C; Shaygannejad V; Van Pesch V; Kappos L; Lechner-Scott J; Bergamaschi R; Turkoglu R; Solaro C; Ramo-Tello C; Iuliano G; Granella F; Van Wijmeersch B; Spitaleri DLA; Fernandez Bolanos R; Slee M; McCombe P; Prevost J; Ampapa R; Ozakbas S; Luis Sanchez-Menoyo J; Soysal A; Vucic OS; Petersen T; Verheul F; Butler E; Hodgkinson S; Sidhom Y; Gouider R; Cristiano E; Olascoaga Urtaza FJ; Laura Saladino M; Barnett M; Deri N; Moore F; Rozsa C; Yamout B; Skibina O; Gray O; Campbell J; Sempere A; Singhal B; Fragoso Y; Shaw C; Kermode A; Petkovska-Boskova T; Taylor B; Simo M; Vella N; Shuey N; Alkhaboori J; Al-Harbi T; Macdonell R; Andres Dominguez J; Kister I; Csepany T; Vrech C; Kovacs K; Adella Sirbu C; Hughes S; Sormani MP; Butzkueven H; Kalincik T, 2020, 'Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058004051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Butzkueven H; Spelman T; Madueno SE; Grand'Maison F; Kalincik T; Hodgkinson S; Skibina O; Butler E, 2020, 'Real-world experience of oral cladribine use in the MSBase Registry', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058006063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
O'Neill D; Hodgkinson S, 2020, 'Short term efficacy and safety outcomes after switching from Anti-CD20 DMTs to Cladribine in a real-world setting', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Back to profile page
https://orcid.org/0000-0002-9029-6663